E3 PreliminaryPreliminaryPEM ?Peer-reviewedMachine draft
Cardiopulmonary responses to exercise in an individual with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome during long-term treatment with intravenous saline: A case study.
Davenport, Todd E, Ward, Michael K, Stevens, Staci R et al. · Work (Reading, Mass.) · 2020 · DOI
Quick Summary
This study followed one woman with ME/CFS who received regular intravenous saline (salt water) infusions over about 2 years. Researchers measured how her heart and lungs responded to exercise tests throughout the treatment. By the end, she recovered faster after exercise, could do more daily activities, and her heart responded better during physical exertion.
Why It Matters
ME/CFS patients often experience chronotropic intolerance (abnormal heart rate responses to activity), which severely limits daily functioning. This case suggests IV saline treatment may help improve cardiovascular function and reduce post-exertional malaise, potentially offering a supportive therapeutic approach worth investigating further in controlled clinical trials.
Observed Findings
- VO2 consumption increased during exercise testing
- Heart rate response improved at peak exertion and at ventilatory anaerobic threshold
- Systolic blood pressure response improved during exercise
- Self-reported recovery time from exercise testing decreased from 5 days to 1-2 days
- Patient reported improved quality of life and capacity for activities of daily living
Inferred Conclusions
- IV saline administration may promote beneficial effects on cardiopulmonary function in ME/CFS
- IV saline treatment may reduce post-exertional malaise severity and recovery time
- Chronotropic intolerance may be a therapeutic target amenable to supportive treatment with IV hydration
Remaining Questions
- Would IV saline treatment produce similar improvements in other ME/CFS patients with chronotropic intolerance?
- What is the optimal frequency, volume, and duration of IV saline administration for ME/CFS?
- What mechanisms explain any potential benefits—improved cardiac output, better oxygen delivery, enhanced vascular function, or other physiologic changes?
What This Study Does Not Prove
This is a single case study and cannot establish that IV saline causes the observed improvements—other factors (placebo effect, natural variation, concurrent lifestyle changes) could explain the results. It does not prove effectiveness in other ME/CFS patients, nor does it establish optimal dosing, patient selection criteria, or long-term safety. Formal randomized controlled trials are needed to validate these preliminary observations.
Tags
Symptom:Post-Exertional MalaiseFatigue
Biomarker:Blood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleExploratory Only
Metadata
- DOI
- 10.3233/WOR-203214
- PMID
- 32623426
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026